IL99899A0 - Vaccines - Google Patents
VaccinesInfo
- Publication number
- IL99899A0 IL99899A0 IL99899A IL9989991A IL99899A0 IL 99899 A0 IL99899 A0 IL 99899A0 IL 99899 A IL99899 A IL 99899A IL 9989991 A IL9989991 A IL 9989991A IL 99899 A0 IL99899 A0 IL 99899A0
- Authority
- IL
- Israel
- Prior art keywords
- vaccines
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919106048A GB9106048D0 (en) | 1991-03-21 | 1991-03-21 | Vaccines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL99899A0 true IL99899A0 (en) | 1992-08-18 |
Family
ID=10691984
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL99899A IL99899A0 (en) | 1991-03-21 | 1991-10-30 | Vaccines |
Country Status (12)
| Country | Link |
|---|---|
| CN (1) | CN1064891A (en) |
| AP (1) | AP368A (en) |
| BR (1) | BR9107294A (en) |
| CZ (1) | CZ195793A3 (en) |
| FI (1) | FI934133A0 (en) |
| GB (1) | GB9106048D0 (en) |
| HU (2) | HUT67011A (en) |
| IL (1) | IL99899A0 (en) |
| MA (1) | MA22381A1 (en) |
| SK (1) | SK82593A3 (en) |
| WO (1) | WO1992016556A1 (en) |
| YU (1) | YU174491A (en) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9105992D0 (en) * | 1991-03-21 | 1991-05-08 | Smithkline Beecham Biolog | Vaccine |
| US6620414B2 (en) | 1992-03-27 | 2003-09-16 | Smithkline Beecham Biologicals (S.A.) | Hepatitis vaccines containing 3-0-deacylated monophoshoryl lipid A |
| DE69405551T3 (en) * | 1993-03-23 | 2005-10-20 | Smithkline Beecham Biologicals S.A. | 3-0-DEAZYLATED MONOPHOSPHORYL LIPID A-CONTAINING VACCINE COMPOSITIONS |
| GB9326253D0 (en) | 1993-12-23 | 1994-02-23 | Smithkline Beecham Biolog | Vaccines |
| GB9706957D0 (en) | 1997-04-05 | 1997-05-21 | Smithkline Beecham Plc | Formulation |
| GB9820525D0 (en) | 1998-09-21 | 1998-11-11 | Allergy Therapeutics Ltd | Formulation |
| GB0000891D0 (en) | 2000-01-14 | 2000-03-08 | Allergy Therapeutics Ltd | Formulation |
| CN1304580C (en) * | 2004-07-09 | 2007-03-14 | 楼伟 | Surface glucoprotein gp160 of recombination expression human acquired immunity defact virus 1 |
| CN101014618B (en) * | 2004-07-23 | 2013-01-02 | 诺华疫苗和诊断有限公司 | Polypeptides for oligomeric assembly of antigens |
| EP2305294B1 (en) | 2004-09-22 | 2015-04-01 | GlaxoSmithKline Biologicals SA | Immunogenic composition for use in vaccination against staphylococcei |
| EP2121745A2 (en) | 2007-02-26 | 2009-11-25 | Oxford Genome Sciences (UK) Limited | Proteins |
| WO2008104803A2 (en) | 2007-02-26 | 2008-09-04 | Oxford Genome Sciences (Uk) Limited | Proteins |
| CA2750581A1 (en) | 2009-01-21 | 2010-07-29 | Oxford Biotherapeutics Ltd. | Pta089 protein |
| WO2011054007A1 (en) | 2009-11-02 | 2011-05-05 | Oxford Biotherapeutics Ltd. | Ror1 as therapeutic and diagnostic target |
| SI2726094T1 (en) | 2011-06-28 | 2017-04-26 | Oxford Biotherapeutics Ltd | Therapeutic and diagnostic target |
| GB201213364D0 (en) | 2012-07-27 | 2012-09-12 | Glaxosmithkline Biolog Sa | Purification process |
| GB201213652D0 (en) | 2012-08-01 | 2012-09-12 | Oxford Biotherapeutics Ltd | Therapeutic and diagnostic target |
| GB201302447D0 (en) | 2013-02-12 | 2013-03-27 | Oxford Biotherapeutics Ltd | Therapeutic and diagnostic target |
| US20180071380A1 (en) | 2015-03-20 | 2018-03-15 | The Regents Of The University Of Michigan | Immunogenic compositions for use in vaccination against bordetella |
| BR112018073676B1 (en) | 2016-05-16 | 2023-10-03 | University Of Virginia Patent Foundation | PEGYLATED LIPOSOMES AND METHODS OF USE |
| EP4112638A1 (en) | 2016-05-16 | 2023-01-04 | Access to Advanced Health Institute | Formulation containing tlr agonist and methods of use |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL89567A0 (en) * | 1988-03-28 | 1989-09-10 | Univ Leland Stanford Junior | Mutated hiv envelope protein |
-
1991
- 1991-03-21 GB GB919106048A patent/GB9106048D0/en active Pending
- 1991-10-25 HU HU9302642A patent/HUT67011A/en unknown
- 1991-10-25 HU HU9302642A patent/HU9302642D0/en unknown
- 1991-10-25 BR BR9107294A patent/BR9107294A/en not_active Application Discontinuation
- 1991-10-25 SK SK825-93A patent/SK82593A3/en unknown
- 1991-10-25 WO PCT/EP1991/002047 patent/WO1992016556A1/en not_active Application Discontinuation
- 1991-10-30 IL IL99899A patent/IL99899A0/en unknown
- 1991-11-01 YU YU174491A patent/YU174491A/en unknown
- 1991-11-04 AP APAP/P/1991/000332A patent/AP368A/en active
- 1991-11-09 CN CN91111514.5A patent/CN1064891A/en active Pending
- 1991-12-30 MA MA22665A patent/MA22381A1/en unknown
-
1993
- 1993-09-21 FI FI934133A patent/FI934133A0/en not_active Application Discontinuation
- 1993-10-25 CZ CZ931957A patent/CZ195793A3/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SK82593A3 (en) | 1994-01-12 |
| BR9107294A (en) | 1994-06-14 |
| WO1992016556A1 (en) | 1992-10-01 |
| CZ195793A3 (en) | 1994-05-18 |
| AP368A (en) | 1994-10-28 |
| MA22381A1 (en) | 1992-07-01 |
| HU9302642D0 (en) | 1994-01-28 |
| YU174491A (en) | 1994-06-10 |
| FI934133A (en) | 1993-09-21 |
| HUT67011A (en) | 1995-01-30 |
| GB9106048D0 (en) | 1991-05-08 |
| CN1064891A (en) | 1992-09-30 |
| FI934133A0 (en) | 1993-09-21 |
| AP9100332A0 (en) | 1992-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB9105992D0 (en) | Vaccine | |
| GB9001766D0 (en) | Vaccines | |
| AP9300541A0 (en) | Vaccines | |
| AP9300530A0 (en) | Vaccines | |
| GB9106048D0 (en) | Vaccines | |
| GB9215233D0 (en) | Vaccines | |
| GB9214871D0 (en) | Vaccines | |
| GB9213559D0 (en) | Vaccines | |
| GB9201023D0 (en) | Vaccines | |
| ZA93919B (en) | Vaccines | |
| GB9226768D0 (en) | Vaccines | |
| GB9119009D0 (en) | Vaccines | |
| GB9110067D0 (en) | Vaccines | |
| GB9124390D0 (en) | Vaccines | |
| ZA926088B (en) | Vaccines | |
| GB9119167D0 (en) | Vaccines | |
| GB9121208D0 (en) | Vaccines | |
| GB9105993D0 (en) | Vaccines | |
| GB9211081D0 (en) | Vaccines | |
| GB9011358D0 (en) | Vaccines | |
| GB9006097D0 (en) | Vaccines | |
| GB9217635D0 (en) | Vaccines | |
| ZA935281B (en) | Vaccines | |
| GB9226283D0 (en) | Vaccines | |
| GB9211318D0 (en) | Vaccines |